OpenVSafe by OpenVAERS
Search V-safe

6B8-28311-00609

2 vaccinations 9 coded responses 22 check-ins 9 free-text entries 2 call cases
Sex
Female
Age at first dose
41-45
ZIP prefix
793 / TX
Registered
2020-12-22
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-22
    Registered in v-safe
  2. 2020-12-22
    Dose 1 — Pfizer-BioNTech
  3. 2020-12-22
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2020-12-27
    Survey response — days 1–6 daily, dose 1
    MedDRA: Abdominal discomfort, Fatigue, Nausea, Pain — Feeling: Good · Site: Pain, Redness, Swelling, Itching
    Free text: All symptoms reported related to the injection site were in the first 48-72hrs. The injection site is normal now. I did experience some fatigue, general aching, mild nausea, and abdominal discomfort in the first 24-48 hours.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2020-12-28
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · Fever · Chills, Headache
    Adult check-in
  6. 2020-12-29
    Health check-in — day 7, dose 1
    Feeling: Good · Fever · Chills
    Adult check-in
  7. 2021-01-05
    Survey response — day 14, dose 1
    MedDRA: Injection site discomfort, Injection site erythema, Injection site nodule, Injection site pruritus, Injection site swelling — Feeling: Good
    Free text: Last Wednesday & Thursday (12/30 & 12/31/2020), my injection site became uncomfortably itchy, swollen with a knot, and reddened. It required multiple topical treatments for any relief.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-01-12
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  9. 2021-01-13
    Dose 2 — Pfizer-BioNTech
  10. 2021-01-13
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · Headache
    Adult check-in
  11. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work, Be unable to do your normal daily activities
    Adult check-in
  12. 2021-01-14
    Report sent to call center — days 1–6 daily, dose 2
    Be unable to work · Be unable to do your normal daily activities
    1 call case(s)
  13. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Joint pains
    Adult check-in
  14. 2021-01-16
    Survey response — days 1–6 daily, dose 2
    MedDRA: Injection site swelling, Lymphadenopathy — Feeling: Good · Site: Pain · Fatigue or tiredness
    Free text: A couple of swollen lymph nodes near injection site.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-01-18
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Fatigue or tiredness
    Free text: Swollen lymph nodes near injection site
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-01-19
    Survey response — days 1–6 daily, dose 2
    MedDRA: Lymphadenopathy — Feeling: Good · Site: Itching · Headache
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-01-20
    Survey response — day 7, dose 2
    MedDRA: Lymphadenopathy — Feeling: Fair · Site: Itching · Headache, Fatigue or tiredness
    Free text: Swollen lymph nodes
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-01-27
    Survey response — day 14, dose 2
    MedDRA: Abdominal discomfort — Feeling: Good
    Free text: Minor GI upset
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  20. 2021-02-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-02-10
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-02-18
    Survey response — day 35, dose 2
    MedDRA: Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Good
    Free text: Post nasal drip and chest congestion
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  23. 2021-02-24
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-14
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-07-16
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  26. 2022-01-14
    Survey response — 12 months, dose 2
    MedDRA: Cough, Respiratory tract congestion, Upper-airway cough syndrome — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Cough, congestion, postnasal drainage
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-01-14
    Report sent to call center — 12 months, dose 2
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  28. 2022-01-17

Vaccinations

DoseDateManufacturerCo-administered
12020-12-22Pfizer-BioNTech
22021-01-13Pfizer-BioNTech

Call center

2 call center cases

1 unsuccessful · 1 priority 2/3 (triaged and no follow up)

See the call center timeline

Free text

Release 1 — days 1–6 daily, dose 1

2020-12-27

Systemic reaction (other): All symptoms reported related to the injection site were in the first 48-72hrs. The injection site is normal now. I did experience some fatigue, general aching, mild nausea, and abdominal discomfort in the first 24-48 hours.

Release 1 — day 14, dose 1

2021-01-05

Symptoms: Last Wednesday & Thursday (12/30 & 12/31/2020), my injection site became uncomfortably itchy, swollen with a knot, and reddened. It required multiple topical treatments for any relief.

Release 2 — days 1–6 daily, dose 2

2021-01-16

Systemic reaction (other): A couple of swollen lymph nodes near injection site.

2021-01-18

Systemic reaction (other): Swollen lymph nodes near injection site

2021-01-19

Systemic reaction (other): Swollen lymph nodes

Release 2 — day 7, dose 2

2021-01-20

Systemic reaction (other): Swollen lymph nodes

Release 2 — day 14, dose 2

2021-01-27

Symptoms: Minor GI upset

Release 4 — day 35, dose 2

2021-02-18

Symptoms: Post nasal drip and chest congestion

Release 10 — 12 months, dose 2

2022-01-14

Symptoms: Cough, congestion, postnasal drainage

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAbdominal discomfort ✓ ✓ ✓
SDCough · · ✓
SDInjection site discomfort ✓ ✓ ✓
SDInjection site erythema ✓ ✓ ✓
SDInjection site nodule ✓ ✓ ✓
SDInjection site pruritus ✓ ✓ ✓
SDInjection site swelling ✓ ✓ ✓
SDRespiratory tract congestion ✓ ✓ ✓
SDUpper-airway cough syndrome ✓ ✓ ✓
SROAbdominal discomfort ✓ ✓ ✓
SROFatigue ✓ ✓ ✓
SROInjection site swelling ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SRONausea ✓ ✓ ✓
SROPain ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release